產(chǎn)品名稱 LXS-196 from BIOVISION, INC.
    產(chǎn)品貨號(hào) B2092-25
    產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià)，電話：010-67529703
    產(chǎn)品規(guī)格 25 mg
    產(chǎn)品品牌 BIOVISION, INC.
    產(chǎn)品概述
    產(chǎn)品詳情
    Edit&nbsp
    Product NameLXS-196
    DescriptionLXS-196 is an orally available protein kinase C (PKC) inhibitor with potential immunosuppressive and antineoplastic activities. Upon oral administration, LXS-196 binds to and inhibits PKC, which prevents the activation of PKC-mediated signaling pathways. This may lead to the induction of cell cycle arrest and apoptosis in susceptible tumor cells. MW: 472.5. Purity ≥98% by HPLC
    Size25 mg
    Concentrationn/a
    Applicationsn/a
    Other Names3-amino-N-(3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl)-6-(3-(trifluoromethyl)pyridin-2-yl)pyrazine-2-carboxamide; NVP-LXS196
    Gene, Accession, CAS #CAS: 1874276-76-2
    Catalog #B2092-25
    Price
    Order / More InfoLXS-196 from BIOVISION, INC.
    Product Specific Referencesn/a
    產(chǎn)品資料 
    <strong id="itm00"><address id="itm00"></address></strong>
    <th id="itm00"></th>
    <acronym id="itm00"><label id="itm00"></label></acronym>

    3. 

    <th id="itm00"></th>